Sunday, April 28, 2024

Technology | 2009.06.05

PolyMedix Initiates Dosing in Second Phase I Clinical Study of Novel Systemic Antibiotic Compound

RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, has

 

For more information, please visit
http://www.businesswire.com/news/home/20090605005033/en

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News